期刊文献+

Upregulation of glucosylceramide synthase protein in papillary thyroid carcinoma 被引量:3

Upregulation of glucosylceramide synthase protein in papillary thyroid carcinoma
原文传递
导出
摘要 Background Glucosylceramide synthase (GCS) can reduce ceramide levels and help cells escape ceramide-induced apoptosis, thus leading to multidrug resistance (MDR). However, its expression and clinical significance in thyroid neoplasms still remain unclear. We aimed to elucidate the expression of GCS and explore its correlation with the clinicopathological characteristics in papillary thyroid carcinomas (PTCs). Methods We retrospectively investigated GCS protein expression level in tissue specimens obtained from 108 consecutive PTC patients by immunohistochemistry and Western blotting. Results GCS was weakly positive or negative in normal follicular cells, but it was frequently overexpressed in PTC cells. GCS overexpression was associated with primary tumor size, local infiltration, lymph node metastasis, and local recurrence, but not associated with gender, age, pathological variants, tumor multifocality, tumor stage or distant metastasis. Western blotting also showed that GCS protein levels were much higher in PTCs' tissues than in normal thyroid tissues. Conclusion GCS was upregulated in PTCs and might be an independent factor affecting prognosis. Background Glucosylceramide synthase (GCS) can reduce ceramide levels and help cells escape ceramide-induced apoptosis, thus leading to multidrug resistance (MDR). However, its expression and clinical significance in thyroid neoplasms still remain unclear. We aimed to elucidate the expression of GCS and explore its correlation with the clinicopathological characteristics in papillary thyroid carcinomas (PTCs). Methods We retrospectively investigated GCS protein expression level in tissue specimens obtained from 108 consecutive PTC patients by immunohistochemistry and Western blotting. Results GCS was weakly positive or negative in normal follicular cells, but it was frequently overexpressed in PTC cells. GCS overexpression was associated with primary tumor size, local infiltration, lymph node metastasis, and local recurrence, but not associated with gender, age, pathological variants, tumor multifocality, tumor stage or distant metastasis. Western blotting also showed that GCS protein levels were much higher in PTCs' tissues than in normal thyroid tissues. Conclusion GCS was upregulated in PTCs and might be an independent factor affecting prognosis.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2013年第24期4660-4664,共5页 中华医学杂志(英文版)
关键词 glucosylceramide synthase papillary thyroid carcinoma immunohistochemistry Western blotting glucosylceramide synthase papillary thyroid carcinoma, immunohistochemistry Western blotting
  • 相关文献

参考文献3

二级参考文献27

  • 1Andrews GA, Kwon M, Clayman G, Edeiken B, Kupferman ME. Technical refinement of ultrasound-guided transoral resection of parapharyngeal/retropharyngeal thyroid carcinoma metastases. Head Neck 2011; 33: 166-170.
  • 2Desuter G, Lonneux M, Plouin-Gaudon I, Jamar F, Coche E, Weynand B, et al. Parapharyngeal metastases from thyroid cancer. Eur J Surg Oncol 2004; 30: 80-84.
  • 3Yuce I, Cagli S, Bayram A, Karasu F, Giiney E. Regional metastatic pattern of papillary thyroid carcinoma. Eur Arch Otorhinolaryngol2010; 267: 437-441.
  • 4Thomas G, Pandey M, Jayasree K, Pradeep VM, Abraham EK, Iype EM, et al. Parapharyngeal metastasis from papillary microcarcinoma of thyroid: report of a case diagnosed by peroral fine needle aspiration. Br J Oral Maxillofac Surg 2002; 40: 229-231.
  • 5Lombardi D, Nicolai P, Antonelli AR, Maroldi R, Farina D, Shaha AR. Parapharyngeal lymph node metastasis: an unusual presentation of papillary thyroid carcinoma. Head Neck 2004; 26: 190-196.
  • 6Qiu ZL, Xu YH, Song HJ, Luo QY. Localization and identification of parapharyngeal metastases from differentiated thyroid carcinoma by 1311-SPECT/CT. Head Neck 2011; 33: 171-177.
  • 7Bozza F, Vigili MG, Ruscito P, Marzetti A, Marzetti F. Surgical management of parapharyngeal space tumours: results of 10-year follow-up. Acta Otorhinolaryngol Ital 2009; 29: 10-15.
  • 8Heimgartner S, Zbaeren P. Thyroid carcinoma presenting as a metastasis to the parapharyngeal space. Otolaryngol Head Neck Surg 2009; 140: 435-436.
  • 9Kaplan SL, Mandel SJ, Muller R, Baloch ZW, Thaler ER, Loevner LA. The role of MR imaging in detecting nodal disease in thyroidectomy patients with rising thyroglobulin levels. Am J Neuroradiol2009; 30: 608-612.
  • 10Otsuki N, Nishikawa T, Iwae S, Saito M, Mohri M, Nibu K. Retropharyngeal node metastasis from papillary thyroid carcinoma. Head Neck 2007; 29: 508-51!.

共引文献26

同被引文献14

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部